ECHO Virus Latest Advances

Type I and Type III Interferons Differentially Shape Antiviral Defense and Epithelial Integrity at the Choroid Plexus.

Journal: bioRxiv : the preprint server for biology

Published: February 23, 2026

Updated lineage information for echovirus 11 pediatric cases in Japan in 2024.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: February 19, 2026

Discovery of Amino Acid-Functionalized Multisubstituted Pyrimidines as Novel Efficient Antiviral Agents Against Enteroviruses.

Journal: Journal of medicinal chemistry

Published: January 22, 2026

Mapping the impact of prolonged microplastics exposure on enteric viral infections using human intestinal organoids.

Journal: Environment international

Published: January 18, 2026

Oral Immunization with the C488A Live-Attenuated Mutant of Coxsackievirus B4E2 (CVB4E2) Induces Potent Immune Response and Protects Balb/c Mice Against Lethal Infection.

Journal: Viruses

Published: January 12, 2026

Cardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditis.

Journal: American journal of physiology. Heart and circulatory physiology

Published: January 06, 2026

Environmental surveillance reveals enterovirus diversity in Jinan, China: detection of types D68, A71, A76, B88, A90, and C99.

Journal: Microbiology spectrum

Published: December 18, 2025

Anti-Coxsackievirus B4 Activity of Serum and Saliva from Mice Exposed to the Virus via the Mucosal Route.

Journal: Microorganisms

Published: December 17, 2025

Isolation and complete genome sequence analysis of an Echovirus 29 strain isolated from a patient of Acute Flaccid Paralysis in India.

Journal: Microbiology resource announcements

Published: December 17, 2025

Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice.

Journal: Viruses

Published: December 15, 2025

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity.

Journal: Journal of biomedical science

Published: December 09, 2025

Coxsackievirus B3 Cleaves INTS10 Through 3C Protease to Facilitate Its Replication.

Journal: International journal of molecular sciences

Published: November 21, 2025

ECHO Virus Latest Advances

Find the Latest Research About ECHO Virus

Type I and Type III Interferons Differentially Shape Antiviral Defense and Epithelial Integrity at the Choroid Plexus.

Type I and Type III Interferons Differentially Shape Antiviral Defense and Epithelial Integrity at the Choroid Plexus.

Updated lineage information for echovirus 11 pediatric cases in Japan in 2024.

Updated lineage information for echovirus 11 pediatric cases in Japan in 2024.

Discovery of Amino Acid-Functionalized Multisubstituted Pyrimidines as Novel Efficient Antiviral Agents Against Enteroviruses.

Discovery of Amino Acid-Functionalized Multisubstituted Pyrimidines as Novel Efficient Antiviral Agents Against Enteroviruses.

Mapping the impact of prolonged microplastics exposure on enteric viral infections using human intestinal organoids.

Mapping the impact of prolonged microplastics exposure on enteric viral infections using human intestinal organoids.

Oral Immunization with the C488A Live-Attenuated Mutant of Coxsackievirus B4E2 (CVB4E2) Induces Potent Immune Response and Protects Balb/c Mice Against Lethal Infection.

Oral Immunization with the C488A Live-Attenuated Mutant of Coxsackievirus B4E2 (CVB4E2) Induces Potent Immune Response and Protects Balb/c Mice Against Lethal Infection.

Cardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditis.

Cardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditis.

Environmental surveillance reveals enterovirus diversity in Jinan, China: detection of types D68, A71, A76, B88, A90, and C99.

Environmental surveillance reveals enterovirus diversity in Jinan, China: detection of types D68, A71, A76, B88, A90, and C99.

Anti-Coxsackievirus B4 Activity of Serum and Saliva from Mice Exposed to the Virus via the Mucosal Route.

Anti-Coxsackievirus B4 Activity of Serum and Saliva from Mice Exposed to the Virus via the Mucosal Route.

Isolation and complete genome sequence analysis of an Echovirus 29 strain isolated from a patient of Acute Flaccid Paralysis in India.

Isolation and complete genome sequence analysis of an Echovirus 29 strain isolated from a patient of Acute Flaccid Paralysis in India.

Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice.

Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice.

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity.

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity.

Coxsackievirus B3 Cleaves INTS10 Through 3C Protease to Facilitate Its Replication.

Coxsackievirus B3 Cleaves INTS10 Through 3C Protease to Facilitate Its Replication.